Investor mix
6 investors on record; lead investors include RA Capital Management, Droia Ventures, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 1 | 17% |
| Other / undisclosed | 2 | 33% |
Covalent medicines platform for expanding the boundaries of drug discovery
6 investors on record; lead investors include RA Capital Management, Droia Ventures, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 1 | 17% |
| Other / undisclosed | 2 | 33% |